Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE0005227235
Mon, 31.03.2025
Biotest AG
Ad-hoc RELEASE
Announcement according to Article 17 European Market Abuse Regulation (MAR)
Biotest AG: Delisting agreement and announced delisting tender offer
eieich, March 31, 2025: Biotest AG (ISIN DE0005227201, ISIN DE0005227235) has today concluded a delisting agreement with its major shareholder, Grifols, S.A., which holds approximate [ … ]
Thu, 06.03.2025
Biotest AG
Ad hoc NOTICE
Notification pursuant to Art. 17 EU Market Abuse Regulation (MAR)
CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future
Dreieich, Germany, 6 March 2025. The Board of Management of Biotest AG announces that Chief Financial Officer Martin Möller will terminate his [ … ]
Wed, 26.02.2025
Biotest AG
Ad-hoc RELEASE
Announcement according to Article 17 European Market Abuse Regulation (MAR)
Biotest publishes preliminary business figures - 2024 forecasts partially exceeded
Dreieich, 26 February 2025: According to preliminary and unaudited figures, the Biotest Group generated revenue of € 726.2 million in the 2024 financial year, compared [ … ]